Adial Pharmaceuticals, Inc. Accrued Liabilities and Other Liabilities
Adial Pharmaceuticals, Inc. (ADIL) had Accrued Liabilities and Other Liabilities of $30.00 thousand as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Notes › Payables and Accruals
us-gaap:AccruedLiabilitiesAndOtherLiabilities · last filed 2023-11-14
- 2023-09-30: Accrued Liabilities and Other Liabilities $30.00K.
- 2023-06-30: Accrued Liabilities and Other Liabilities $20.00K.
- 2023-03-31: Accrued Liabilities and Other Liabilities $21.02K.
- 2022-12-31: Accrued Liabilities and Other Liabilities $175.00K.
| Period end | Accrued Liabilities and Other Liabilities |
|---|---|
| 2023-09-30 | $30.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $20.00K 10-Q/A · filed 2023-10-30 |
| 2023-03-31 | $21.02K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $175.00K 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |